Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2022-12-12 Sale |
2022-12-14 5:06 pm |
AbbVie Inc. | ABBV | RICHMOND TIMOTHY J. EVP, CHIEF HR OFFICER |
42,370 | $163.44 | $6,925,018 | 13,837 (Direct) |
View |
2022-05-23 Sale |
2022-05-25 4:58 pm |
AbbVie Inc. | ABBV | SEVERINO MICHAEL Vice Chairman |
79,801 | $150.9 | $12,041,780 | 233,769 (Direct) |
View |
2022-05-16 Sale(A) |
2022-05-20 5:03 pm |
AbbVie Inc. | ABBV | Gosebruch Henry O EVP, Chief Strategy Officer |
83,960 | $155 | $13,013,800 | 98,761 (Indirect Direct) |
View |
2022-03-01 Sale(A) |
2022-05-20 5:00 pm |
AbbVie Inc. | ABBV | Gosebruch Henry O EVP, Chief Strategy Officer |
25,000 | $147.29 | $3,682,189 | 98,580 (Indirect Direct) |
View |
2022-05-16 Sale |
2022-05-18 5:12 pm |
AbbVie Inc. | ABBV | SEVERINO MICHAEL Vice Chairman |
200,000 | $154.25 | $30,849,488 | 237,397 (Direct) |
View |
2022-05-16 Sale |
2022-05-18 5:12 pm |
AbbVie Inc. | ABBV | Gosebruch Henry O EVP, Chief Strategy Officer |
83,960 | $155 | $13,013,800 | 98,580 (Indirect Direct) |
View |
2022-05-06 Sale |
2022-05-10 5:05 pm |
AbbVie Inc. | ABBV | SEVERINO MICHAEL Vice Chairman |
300,000 | $151.12 | $45,336,288 | 360,060 (Direct) |
View |
2022-03-24 Sale |
2022-03-25 5:09 pm |
AbbVie Inc. | ABBV | Stewart Jeffrey Ryan EVP, Chief Commercial Officer |
27,690 | $159.2 | $4,408,375 | 62,279 (Indirect Direct) |
View |
2022-03-09 Sale |
2022-03-11 5:05 pm |
AbbVie Inc. | ABBV | Durkin Brian L VP, Controller |
18,628 | $150.01 | $2,794,301 | 19,094 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2023-02-16 Option Award |
2023-02-21 6:08 pm |
2024-02-16 2033-02-15 |
AbbVie Inc. | ABBV | Durkin Brian L VP, CONTROLLER |
31,989 | $0 | 51,083 (Direct) |
View |
2023-02-16 Option Award |
2023-02-21 6:07 pm |
2024-02-16 2033-02-15 |
AbbVie Inc. | ABBV | Hudson Thomas J SVP, R&D AND CSO |
83,279 | $0 | 129,507 (Direct) |
View |
2023-02-16 Option Award |
2023-02-21 6:06 pm |
2024-02-16 2033-02-15 |
AbbVie Inc. | ABBV | GONZALEZ RICHARD A CHAIRMAN OF THE BOARD AND CEO |
371,688 | $0 | 904,356 (Direct) |
View |
2023-02-16 Option Award |
2023-02-21 6:02 pm |
2024-02-16 2033-02-15 |
AbbVie Inc. | ABBV | Stewart Jeffrey Ryan EVP, COMMERCIAL OPERATIONS |
91,336 | $0 | 153,615 (Direct) |
View |
2023-02-16 Option Award |
2023-02-21 6:00 pm |
2024-02-16 2033-02-15 |
AbbVie Inc. | ABBV | RICHMOND TIMOTHY J. EVP, CHIEF HR OFFICER |
101,196 | $0 | 115,033 (Direct) |
View |
2023-02-16 Option Award |
2023-02-21 5:59 pm |
2024-02-16 2033-02-15 |
AbbVie Inc. | ABBV | Michael Robert A. VICE CHAIRMAN |
154,680 | $0 | 192,557 (Direct) |
View |
2022-12-31 Option Award |
2023-01-03 5:06 pm |
N/A N/A |
AbbVie Inc. | ABBV | Alpern Robert J Director |
46 | $161.61 | 8,723 (Direct) |
View |
2022-12-31 Option Award |
2023-01-03 5:05 pm |
N/A N/A |
AbbVie Inc. | ABBV | RAPP EDWARD J Director |
239 | $161.61 | 23,256 (Direct) |
View |
2022-12-12 Exercise |
2022-12-14 5:06 pm |
2017-02-18 2026-02-17 |
AbbVie Inc. | ABBV | RICHMOND TIMOTHY J. EVP, CHIEF HR OFFICER |
42,370 | $0 | 13,837 (Direct) |
View |
2022-12-12 Exercise |
2022-12-14 5:06 pm |
N/A N/A |
AbbVie Inc. | ABBV | RICHMOND TIMOTHY J. EVP, CHIEF HR OFFICER |
42,370 | $54.86 | 13,837 (Direct) |
View |
Ownership |
2022-10-27 5:01 pm |
N/A N/A |
AbbVie Inc. | ABBV | Siatis Perry C EVP, GC and Secretary |
0 | $0 | 33,536 (Direct) |
View |
2022-09-30 Option Award |
2022-10-04 5:08 pm |
N/A N/A |
AbbVie Inc. | ABBV | RAPP EDWARD J Director |
288 | $134.21 | 22,806 (Direct) |
View |
2022-09-30 Option Award |
2022-10-04 5:02 pm |
N/A N/A |
AbbVie Inc. | ABBV | Alpern Robert J Director |
55 | $134.21 | 8,598 (Direct) |
View |
Ownership |
2022-07-08 1:11 pm |
N/A N/A |
AbbVie Inc. | ABBV | Reents Scott T SVP, Chief Financial Officer |
0 | $0 | 101,780 (Direct) |
View |
2022-06-30 Option Award |
2022-07-05 5:25 pm |
N/A N/A |
AbbVie Inc. | ABBV | Alpern Robert J Director |
47 | $153.16 | 8,458 (Direct) |
View |
2022-06-30 Option Award |
2022-07-05 5:23 pm |
N/A N/A |
AbbVie Inc. | ABBV | RAPP EDWARD J Director |
237 | $153.16 | 22,296 (Direct) |
View |
2022-05-23 Exercise |
2022-05-25 4:58 pm |
2019-02-15 2028-02-14 |
AbbVie Inc. | ABBV | SEVERINO MICHAEL Vice Chairman |
46,320 | $114.36 | 233,769 (Direct) |
View |
2022-05-23 Exercise |
2022-05-25 4:58 pm |
2022-02-18 2031-02-17 |
AbbVie Inc. | ABBV | SEVERINO MICHAEL Vice Chairman |
21,739 | $105.92 | 233,769 (Direct) |
View |
2022-05-23 Exercise |
2022-05-25 4:58 pm |
2021-02-20 2030-02-19 |
AbbVie Inc. | ABBV | SEVERINO MICHAEL Vice Chairman |
11,742 | $93.5 | 233,769 (Direct) |
View |
2022-05-16 Exercise(A) |
2022-05-20 5:03 pm |
2017-02-18 2026-02-17 |
AbbVie Inc. | ABBV | Gosebruch Henry O EVP, Chief Strategy Officer |
83,960 | $54.86 | 98,761 (Direct) |
View |
2022-05-17 Exercise |
2022-05-18 5:12 pm |
2020-02-21 2029-02-20 |
AbbVie Inc. | ABBV | SEVERINO MICHAEL Vice Chairman |
64,485 | $79.02 | 237,397 (Direct) |
View |
2022-05-16 Exercise |
2022-05-18 5:12 pm |
2020-02-21 2029-02-20 |
AbbVie Inc. | ABBV | SEVERINO MICHAEL Vice Chairman |
29,121 | $79.2 | 237,397 (Direct) |
View |
2022-05-16 Exercise |
2022-05-18 5:12 pm |
2018-02-16 2027-02-15 |
AbbVie Inc. | ABBV | SEVERINO MICHAEL Vice Chairman |
70,879 | $61.36 | 237,397 (Direct) |
View |
2022-05-17 Exercise |
2022-05-18 5:12 pm |
2021-02-20 2030-02-19 |
AbbVie Inc. | ABBV | SEVERINO MICHAEL Vice Chairman |
64,636 | $93.5 | 237,397 (Direct) |
View |
2022-05-16 Exercise |
2022-05-18 5:12 pm |
2017-02-18 2026-02-17 |
AbbVie Inc. | ABBV | Gosebruch Henry O EVP, Chief Strategy Officer |
83,960 | $54.86 | 98,580 (Direct) |
View |
2022-05-11 Tax Withholding |
2022-05-13 5:46 pm |
N/A N/A |
AbbVie Inc. | ABBV | Strom Carrie C SVP & Pres Global Allerg Aesth |
2,876 | $152.09 | 40,663 (Direct) |
View |
2022-05-06 Exercise |
2022-05-10 5:05 pm |
2015-06-02 2024-06-01 |
AbbVie Inc. | ABBV | SEVERINO MICHAEL Vice Chairman |
74,309 | $54.44 | 360,060 (Direct) |
View |
2022-05-09 Exercise |
2022-05-10 5:05 pm |
2016-02-19 2025-02-18 |
AbbVie Inc. | ABBV | SEVERINO MICHAEL Vice Chairman |
104,480 | $58.88 | 360,060 (Direct) |
View |
2022-05-06 Exercise |
2022-05-10 5:05 pm |
2017-02-18 2026-02-17 |
AbbVie Inc. | ABBV | SEVERINO MICHAEL Vice Chairman |
91,990 | $54.86 | 360,060 (Direct) |
View |
2022-05-10 Exercise |
2022-05-10 5:05 pm |
2018-02-16 2027-02-15 |
AbbVie Inc. | ABBV | SEVERINO MICHAEL Vice Chairman |
29,221 | $61.36 | 360,060 (Direct) |
View |
2022-05-07 Tax Withholding |
2022-05-09 5:15 pm |
N/A N/A |
AbbVie Inc. | ABBV | Strom Carrie C SVP & Pres Global Allerg Aesth |
234 | $152.83 | 43,539 (Direct) |
View |
2022-05-06 Option Award |
2022-05-09 5:14 pm |
N/A N/A |
AbbVie Inc. | ABBV | WADDELL FREDERICK H Director |
1,421 | $0 | 24,983 (Direct) |
View |
2022-05-06 Option Award |
2022-05-09 5:14 pm |
N/A N/A |
AbbVie Inc. | ABBV | TILTON GLENN F Director |
1,421 | $0 | 47,939 (Direct) |
View |
2022-05-06 Option Award |
2022-05-09 5:13 pm |
N/A N/A |
AbbVie Inc. | ABBV | Roberts Rebecca B Director |
1,421 | $0 | 9,753 (Direct) |
View |
2022-05-06 Option Award |
2022-05-09 5:13 pm |
N/A N/A |
AbbVie Inc. | ABBV | RAPP EDWARD J Director |
1,421 | $0 | 38,972 (Direct) |
View |
2022-05-06 Option Award |
2022-05-09 5:13 pm |
N/A N/A |
AbbVie Inc. | ABBV | MEYER MELODY B Director |
1,421 | $0 | 12,523 (Direct) |
View |
2022-05-06 Option Award |
2022-05-09 5:12 pm |
N/A N/A |
AbbVie Inc. | ABBV | Hart Brett J Director |
1,421 | $0 | 15,497 (Direct) |
View |
2022-05-06 Option Award |
2022-05-09 5:11 pm |
N/A N/A |
AbbVie Inc. | ABBV | FREYMAN THOMAS C Director |
1,421 | $0 | 130,658 (Direct) |
View |
2022-05-06 Option Award |
2022-05-09 5:10 pm |
N/A N/A |
AbbVie Inc. | ABBV | BURNSIDE WILLIAM H.L. Director |
1,421 | $0 | 22,983 (Direct) |
View |
2022-05-06 Option Award |
2022-05-09 5:10 pm |
N/A N/A |
AbbVie Inc. | ABBV | AUSTIN ROXANNE S Director |
1,421 | $0 | 50,705 (Direct) |
View |
2022-05-06 Option Award |
2022-05-09 5:09 pm |
N/A N/A |
AbbVie Inc. | ABBV | Alpern Robert J Director |
1,421 | $0 | 31,542 (Direct) |
View |
2022-03-31 Option Award |
2022-04-04 5:16 pm |
N/A N/A |
AbbVie Inc. | ABBV | LIDDY EDWARD M Director |
177 | $162.11 | 28,474 (Direct) |
View |
2022-03-31 Option Award |
2022-04-04 5:15 pm |
N/A N/A |
AbbVie Inc. | ABBV | RAPP EDWARD J Director |
217 | $162.11 | 21,860 (Direct) |
View |
2022-03-31 Option Award |
2022-04-04 5:14 pm |
N/A N/A |
AbbVie Inc. | ABBV | Alpern Robert J Director |
44 | $162.11 | 8,335 (Direct) |
View |
2022-03-24 Exercise |
2022-03-25 5:09 pm |
2016-02-19 2025-02-18 |
AbbVie Inc. | ABBV | Stewart Jeffrey Ryan EVP, Chief Commercial Officer |
27,690 | $58.88 | 62,279 (Direct) |
View |
2022-03-09 Exercise |
2022-03-11 5:05 pm |
2020-02-21 2029-02-20 |
AbbVie Inc. | ABBV | Durkin Brian L VP, Controller |
11,682 | $79.02 | 19,094 (Direct) |
View |
2022-03-05 Tax Withholding |
2022-03-07 5:01 pm |
N/A N/A |
AbbVie Inc. | ABBV | Strom Carrie C SVP & Pres Global Allerg Aesth |
803 | $150.56 | 43,773 (Direct) |
View |
2022-03-02 Tax Withholding |
2022-03-02 5:04 pm |
N/A N/A |
AbbVie Inc. | ABBV | Strom Carrie C SVP & Pres Global Allerg Aesth |
810 | $147.69 | 44,576 (Direct) |
View |